Workshop for stakeholders in the ATMP field

The workshop places a strong emphasis on active dialogue between participants and speakers. Members of the APV focus group “Pharmaceutical Biotechnology” will also be present on-site to support professional exchange.

The event combines in-depth knowledge transfer to support market access of ATMP with targeted discussion of specific questions related to individual product portfolios.

Part of the workshop will be led by Dr. Hans-Georg Eckert, Managing Director and Senior GMP Consultant at Valicare GmbH. As a qualified biologist, he draws on nearly 30 years of professional experience in guiding and implementing GMP compliance. He is supported by Ralf Sanzenbacher, PhD, from the Paul-Ehrlich-Institute, who currently serves as Senior Scientific Assessor in the Department of Hematology, Cell and Gene Therapy.

Who should attend?:

• Stakeholders in the Advanced Therapy Medicinal Product (ATMP) field
• Executives of small- and medium-sized companies
• Experts in pharmaceutical development, production, and quality control of cell and gene therapeutics
• Master's and Ph.D. students with a strong connection to the topic or those working in the relevant pharmaceutical business area

Following the workshop, the APV (Association for Pharmaceutical Technology) invites interested students and young professionals to a free roadshow (6:30-8:00 pm).

APV board members will present the mission, vision, and activities of the association.

Did we catch your interest? To register, please use the following links:

Registration for workshop: Interactive workshop

Registration for roadshow: APV Roadshow